BIORESTORATIVE THERAPIES, INC. (BRTX) Total liabilities 2016–2025
BIORESTORATIVE THERAPIES, INC. (BRTX) total liabilities at each fiscal year-end, per SEC filings.
$3.7MFY2025 · since FY2016: $6.6M → $3.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.7M | -0.7% |
| FY2024 | $3.7M | +43.8% |
| FY2023 | $2.6M | -57.6% |
| FY2022 | $6.1M | +617.4% |
| FY2021 | $856,497 | -84.9% |
| FY2020 | $5.7M | -60.1% |
| FY2019 | $14.2M | +44.8% |
| FY2018 | $9.8M | +14.4% |
| FY2017 | $8.6M | +30.6% |
| FY2016 | $6.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More BRTX financial trends
BRTX RevenueBRTX Net incomeBRTX Net marginBRTX Gross profitBRTX Gross marginBRTX Operating incomeBRTX Operating marginBRTX Operating cash flowBRTX Free cash flowBRTX Capital expendituresBRTX Return on equityBRTX Stock buybacksBRTX Dividends paidBRTX Total assetsBRTX Shareholders’ equityBRTX overview →